RNAC logo

Cartesian Therapeutics (RNAC) Operating Expenses

Annual Operating Expenses

$112.42 M
+$16.18 M+16.81%

31 December 2023

RNAC Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$17.96 M
-$1.73 M-8.77%

01 September 2024

RNAC Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+16.8%-8.4%
3 y3 years+53.1%-31.9%
5 y5 years+70.5%+52.3%

RNAC Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+53.1%-59.7%at low
5 y5 yearsat high+90.1%-59.7%+52.3%
alltimeall timeat high+509.7%-59.7%+162.4%

Cartesian Therapeutics Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$17.96 M(-8.8%)
June 2024
-
$19.69 M(+2.6%)
Mar 2024
-
$19.19 M(-57.0%)
Dec 2023
$112.42 M(+16.8%)
$44.60 M(+127.4%)
Sept 2023
-
$19.62 M(-17.9%)
June 2023
-
$23.89 M(-1.8%)
Mar 2023
-
$24.32 M(-3.8%)
Dec 2022
$96.24 M(+7.3%)
-
Dec 2022
-
$25.29 M(+13.4%)
Sept 2022
-
$22.31 M(-12.2%)
June 2022
-
$25.41 M(+9.4%)
Mar 2022
-
$23.23 M(-10.2%)
Dec 2021
$89.67 M(+22.1%)
$25.86 M(-2.0%)
Sept 2021
-
$26.40 M(+37.4%)
June 2021
-
$19.21 M(+5.5%)
Mar 2021
-
$18.21 M(-8.3%)
Dec 2020
$73.42 M(+24.2%)
$19.85 M(+8.0%)
Sept 2020
-
$18.38 M(+12.3%)
June 2020
-
$16.37 M(-13.0%)
Mar 2020
-
$18.82 M(-2.1%)
DateAnnualQuarterly
Dec 2019
$59.13 M(-10.3%)
$19.22 M(+63.0%)
Sept 2019
-
$11.79 M(-27.4%)
June 2019
-
$16.25 M(+36.9%)
Mar 2019
-
$11.87 M(-23.0%)
Dec 2018
$65.92 M(+3.0%)
$15.40 M(-3.4%)
Sept 2018
-
$15.94 M(-15.1%)
June 2018
-
$18.77 M(+18.7%)
Mar 2018
-
$15.81 M(-18.0%)
Dec 2017
$63.99 M(+49.7%)
$19.29 M(+39.0%)
Sept 2017
-
$13.88 M(-12.7%)
June 2017
-
$15.90 M(+6.6%)
Mar 2017
-
$14.92 M(-11.1%)
Dec 2016
$42.75 M(+36.5%)
$16.79 M(+97.2%)
Sept 2016
-
$8.52 M(+1.2%)
June 2016
-
$8.42 M(-6.8%)
Mar 2016
-
$9.03 M(-2.3%)
Dec 2015
$31.32 M(+69.8%)
$9.24 M(+20.4%)
Sept 2015
-
$7.68 M(+1.7%)
June 2015
-
$7.55 M(+10.3%)
Mar 2015
-
$6.84 M
Dec 2014
$18.44 M
-

FAQ

  • What is Cartesian Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual operating expenses year-on-year change?
  • What is Cartesian Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly operating expenses year-on-year change?

What is Cartesian Therapeutics annual total operating expenses?

The current annual operating expenses of RNAC is $112.42 M

What is the all time high annual operating expenses for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual total operating expenses is $112.42 M

What is Cartesian Therapeutics annual operating expenses year-on-year change?

Over the past year, RNAC annual total operating expenses has changed by +$16.18 M (+16.81%)

What is Cartesian Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of RNAC is $17.96 M

What is the all time high quarterly operating expenses for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly total operating expenses is $44.60 M

What is Cartesian Therapeutics quarterly operating expenses year-on-year change?

Over the past year, RNAC quarterly total operating expenses has changed by -$1.65 M (-8.43%)